vimarsana.com
Home
Live Updates
Lexaria Bioscience Corp.: Lexaria Comments on Study Examinin
Lexaria Bioscience Corp.: Lexaria Comments on Study Examinin
Lexaria Bioscience Corp.: Lexaria Comments on Study Examining Cannabinoids and SARS-CoV-2
"Cannabinoids have the potential to prevent as well as treat infection by SARS-CoV-2"KELOWNA, BC / ACCESSWIRE / January 18, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or
Related Keywords
Chris Bunka ,
Lexaria Bioscience ,
George Jurcic ,
Richard Van Breeman ,
Exchange Commission ,
Pfizer ,
Lexaria Bioscience Corp ,
Company Or Lexaria ,
Drug Administration ,
Gilead Sciences Inc ,
Nasdaq ,
Block Cellular Entry ,
Lexaria ,
Ioscience ,
Orp ,
Comments ,
Study ,
Examining ,
Cannabinoids ,
Cars ,